Urothelial cancer
41 – 50 of 100
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The Urothelial Transcriptomic Response to Interferon Gamma : Implications for Bladder Cancer Prognosis and Immunotherapy
(
- Contribution to journal › Article
-
Mark
Immunohistochemistry subtyping of urothelial carcinoma is feasible in the daily practice
(
- Contribution to journal › Article
-
Mark
Robot-assisted nephroureterectomy for upper tract urothelial carcinoma—feasibility and complications : a single center experience
(
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
(
- Contribution to journal › Scientific review
-
Mark
Diagnostic and prognostic implications of a three-antibody molecular subtyping algorithm for non-muscle invasive bladder cancer
(
- Contribution to journal › Article
-
Mark
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
(
- Contribution to journal › Article
-
Mark
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
(
- Contribution to journal › Article
-
Mark
Urostomal ileal conduit complications in association with abdominal wall mesh implantation
(
- Contribution to journal › Article
-
Mark
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer—Stromal gene expressions show higher prognostic values than intrinsic tumor genes
(
- Contribution to journal › Article
- 2021
-
Mark
Personalized medicine for bladder cancer
(
- Contribution to journal › Article